GDX vs XBI
VanEck Gold Miners ETF vs SPDR S&P Biotech ETF
GDX$86.19
VanEck Gold Miners ETF
Major gold mining companies.
Expense: 0.51%Yield: 0.82%
XBI$156.41
SPDR S&P Biotech ETF
Equal-weight biotech stocks in the S&P Biotech Index.
Expense: 0.35%Yield: 0.35%
Quick take
- • XBI has the lower expense ratio at 0.35% vs 0.51% for GDX.
- • GDX pays a higher dividend yield (0.82%).
Side-by-side metrics
| Metric | GDX | XBI |
|---|---|---|
Expense ratio Annual fee. Lower is better. | 0.51% | 0.35% |
Dividend yield Trailing 12-month yield. | 0.82% | 0.35% |
AUM Assets under management — bigger funds are typically more liquid. | $23.82B | $10.92B |
YTD return | 6.63% | 28.80% |
1-year return | — | — |
3-year return Annualized. | — | — |
5-year return Annualized. | — | — |
10-year return Annualized. | — | — |
Beta (3Y) Volatility relative to the market. Closer to 1 = market-like. | 0.98 | 1.01 |
P/E ratio | 13.66 | — |
Last price | $86.19 | $156.41 |
Inception | — | — |
Issuer | VanEck | State Street |
GDX top holdings
Top holdings · GDX
| NEM | Newmont Corp | 11.62% |
| AEM.TO | Agnico Eagle Mines Ltd | 11.26% |
| ABX.TO | Barrick Mining Corp | 8.18% |
| WPM.TO | Wheaton Precious Metals Corp | 5.48% |
| FNV.TO | Franco-Nevada Corp | 5.45% |
| AU | Anglogold Ashanti PLC | 4.73% |
| GFI | Gold Fields Ltd ADR | 3.92% |
| K.TO | Kinross Gold Corp | 3.65% |
| NST.AX | Northern Star Resources Ltd | 3.28% |
| PAAS.TO | Pan American Silver Corp | 2.55% |
Sector breakdown · GDX
Basic Materials100.0%
XBI top holdings
Top holdings · XBI
| MRNA | Moderna Inc | 2.37% |
| NTRA | Natera Inc | 1.82% |
| HALO | Halozyme Therapeutics Inc | 1.77% |
| TWST | Twist Bioscience Corp | 1.77% |
| BIIB | Biogen Inc | 1.75% |
| AMGN | Amgen Inc | 1.73% |
| EXEL | Exelixis Inc | 1.73% |
| UTHR | United Therapeutics Corp | 1.72% |
| ABBV | AbbVie Inc | 1.71% |
| GILD | Gilead Sciences Inc | 1.70% |
Sector breakdown · XBI
Financial Services0.6%
Healthcare99.3%
About GDX
GDX (VanEck Gold Miners ETF) is Major gold mining companies. Managed by VanEck, the fund carries $23.8B in assets under management, an expense ratio of 0.51%, a dividend yield of 0.82%. Its largest holding is Newmont Corp (NEM), which represents 11.6% of the portfolio. Basic Materials is the fund's largest sector exposure at 100.0%.
About XBI
XBI (SPDR S&P Biotech ETF) is Equal-weight biotech stocks in the S&P Biotech Index. Managed by State Street, the fund carries $10.9B in assets under management, an expense ratio of 0.35%, a dividend yield of 0.35%. Its largest holding is Moderna Inc (MRNA), which represents 2.4% of the portfolio. Financial Services is the fund's largest sector exposure at 0.6%.